Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.

Dos Santos Ferreira AC, Fernandes RA, Kwee JK, Klumb CE.

J Cancer Res Clin Oncol. 2012 Feb;138(2):317-25. doi: 10.1007/s00432-011-1093-y. Epub 2011 Dec 1.

PMID:
22131152
2.

Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.

Hui KF, Leung YY, Yeung PL, Middeldorp JM, Chiang AK.

Br J Haematol. 2014 Dec;167(5):639-50. doi: 10.1111/bjh.13089. Epub 2014 Aug 25.

PMID:
25155625
3.

TGFbeta-mediated apoptosis of Burkitt's lymphoma BL41 cells is associated with the relocation of mitochondrial BimEL.

Clybouw C, Mchichi BE, Hadji A, Portier A, Auffredou MT, Arnoult D, Leca G, Vazquez A.

Oncogene. 2008 May 29;27(24):3446-56. doi: 10.1038/sj.onc.1211009. Epub 2008 Jan 14.

PMID:
18193085
4.

Functional and biological analysis of Bcl-xL expression in human osteosarcoma.

Wang ZX, Yang JS, Pan X, Wang JR, Li J, Yin YM, De W.

Bone. 2010 Aug;47(2):445-54. doi: 10.1016/j.bone.2010.05.027. Epub 2010 May 23.

PMID:
20580954
5.

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

Tahir SK, Yang X, Anderson MG, Morgan-Lappe SE, Sarthy AV, Chen J, Warner RB, Ng SC, Fesik SW, Elmore SW, Rosenberg SH, Tse C.

Cancer Res. 2007 Feb 1;67(3):1176-83.

6.

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

Richter-Larrea JA, Robles EF, Fresquet V, Beltran E, Rullan AJ, Agirre X, Calasanz MJ, Panizo C, Richter JA, Hernandez JM, Roman-Gomez J, Prosper F, Martinez-Climent JA.

Blood. 2010 Oct 7;116(14):2531-42. doi: 10.1182/blood-2010-02-268003. Epub 2010 Jun 22.

8.

Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells.

Jasek E, Lis GJ, Jasinska M, Jurkowska H, Litwin JA.

Anticancer Res. 2012 Jul;32(7):2791-9.

PMID:
22753739
9.
10.

Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.

Liang CZ, Zhang JK, Shi Z, Liu B, Shen CQ, Tao HM.

Cancer Chemother Pharmacol. 2012 Feb;69(2):317-31. doi: 10.1007/s00280-011-1699-4. Epub 2011 Jun 30.

PMID:
21717192
11.

Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.

Ferreira AC, Robaina MC, Rezende LM, Severino P, Klumb CE.

Ann Hematol. 2014 Jun;93(6):983-93. doi: 10.1007/s00277-014-2021-4. Epub 2014 Feb 28.

PMID:
24577510
12.

Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.

Arisan ED, Kutuk O, Tezil T, Bodur C, Telci D, Basaga H.

Breast Cancer Res Treat. 2010 Jan;119(2):271-81. doi: 10.1007/s10549-009-0343-z. Epub 2009 Feb 24.

PMID:
19238538
13.

Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.

Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M, Marcucci G.

Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2390-8.

PMID:
12766035
14.
16.

The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.

Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.

Anticancer Res. 2002 May-Jun;22(3):1361-8.

PMID:
12168812
17.

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.

Stauber RH, Knauer SK, Habtemichael N, Bier C, Unruhe B, Weisheit S, Spange S, Nonnenmacher F, Fetz V, Ginter T, Reichardt S, Liebmann C, Schneider G, Krämer OH.

Oncotarget. 2012 Jan;3(1):31-43.

19.

Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.

Zantl N, Weirich G, Zall H, Seiffert BM, Fischer SF, Kirschnek S, Hartmann C, Fritsch RM, Gillissen B, Daniel PT, Häcker G.

Oncogene. 2007 Oct 25;26(49):7038-48. Epub 2007 May 7.

PMID:
17486061
20.

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.

Inoue S, Riley J, Gant TW, Dyer MJ, Cohen GM.

Leukemia. 2007 Aug;21(8):1773-82. Epub 2007 May 24.

PMID:
17525724
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk